Medical Center Evrohealth EOOD

At Medical Center Evrohealth EOOD in Sofia, clinical research in these areas focuses on conditions such as severe hypertriglyceridemia and hepatic impairment. The trials are designed to assess whether new therapies can improve metabolic control and better understand how liver function may affect treatment safety and effectiveness.

• Testing a potential treatment for severe hypertriglyceridemia
• Evaluating the impact of hepatic impairment on treatment response
• Assessing safety and tolerability in metabolic and liver-related conditions

These studies reflect a strong interest in improving care for patients with complex metabolic and digestive system disorders.

Research in immune-mediated diseases at this site includes studies of primary discoid lupus erythematosus, with a focus on reducing active disease symptoms and exploring new options for disease control. The work aims to improve treatment effectiveness for patients living with chronic inflammatory conditions.

• Studying therapy options for primary discoid lupus erythematosus
• Measuring changes in active disease activity
• Evaluating whether a new approach can improve immune disease management

This area highlights ongoing efforts to advance care for people affected by autoimmune skin and systemic immune disorders.

Clinical trials in this therapeutic area at Medical Center Evrohealth EOOD are centered on hidradenitis suppurativa, a painful chronic skin condition. The research is aimed at determining whether new treatments can lessen symptoms, improve skin health, and provide better disease control compared with standard care or placebo.

• Evaluating treatment effectiveness in hidradenitis suppurativa
• Assessing symptom improvement in moderate to severe disease
• Supporting development of better options for chronic inflammatory skin disease

These studies contribute to broader efforts in dermatology and connective tissue disease research.